THU0155 The addition of another disease-modifying anti-rheumatic drug to methotrexate in place of infliximab improves the rate of infliximab-free sustained remission
Rheumatoid arthritis – non-biologic treatment and small molecules
THU0155 The addition of another disease-modifying anti-rheumatic drug to methotrexate in place of infliximab improves the rate of infliximab-free sustained remission